Tue. 9 Aug 2022, 4:10pm ET Benzinga Earnings, News
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.44) per share. This is a 68.35 percent increase over losses of $(1.39) per share from the same period last year. The company reported $4.19 million in sales this quarter. This is a 184.01 percent increase over sales of $1.48 million the same period last year.